WOLLVAC Poultry Vaccine Solution

Poultry Mycoplasma Vaccine

WOLLVAC provides inactivated Mycoplasma vaccine options for Mycoplasma gallisepticum and Mycoplasma synoviae, with combination products, strain-tropism guidance and technical support.

MG

Mycoplasma gallisepticum

Respiratory and reproductive

MS

Mycoplasma synoviae

Respiratory and joint

Vertical + horizontal

Transmission Routes

Persistent flock spread

CR + WH + DM

Antigen Direction

Tissue-tropism strategy

What Are MG and MS in Poultry?

Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) spread through respiratory droplets, dust, contaminated feed and water, direct contact and vertical transmission through eggs. Persistent infection across generations makes prevention and flock monitoring especially important.

Key point: MG is associated with respiratory and reproductive tract problems. MS may cause respiratory infection, joint swelling, bursitis and tenosynovitis, and it can remain subclinical in caged birds.

What Are MG and MS in Poultry

Clinical Signs And Production Impact

Mycoplasma Can Cause Chronic and Hidden Production Losses

MG and MS can damage the respiratory, reproductive and musculoskeletal systems. Chronic or subclinical infection may reduce flock performance before obvious signs appear.

01

Respiratory Inflammation

Ciliary damage and respiratory inflammation impair mucociliary clearance and increase secondary infection risk.

02

Reproductive Tract Losses

Inflammation is associated with reduced egg production and abnormal eggshell quality.

03

Joint and Synovial Disease

MS may cause joint swelling, bursitis, tenosynovitis, fever and growth retardation.

04

Vertical Transmission

Egg transmission can introduce infection at hatch and accelerate flock spread.

Respiratory tract inflammation: Normal cilia

Respiratory tract inflammation: Normal cilia

Respiratory tract inflammation and cilia affected by mycoplasma infection

Respiratory tract inflammation:Cilia affected by mycoplasma infection

Reproductive tract inflammation associated with reduced egg production, abnormal eggshell

Reproductive tract inflammation: Associated with reduced egg production, abnormal eggshell,

Reproductive tract inflammationFallopian tube inflammation

Reproductive tract inflammationFallopian tube inflammation

Joint inflammation Knee joint swelling

Joint inflammation: Knee joint swelling

Joint inflammation Keel swelling

Joint inflammation: Keel swelling

The global prevalence of MG and MS

Why Mycoplasma Strain and Tissue Tropism Matter

Field strains can differ in tissue tropism and immunogenicity. The supplied material highlights respiratory-tropic, reproductive-tropic and joint-tropic antigen directions for broader prevention planning.

Product communication point: Confirm the target country, MG or MS status, flock type, vertical transmission risk, clinical signs, previous medication and whether coryza coverage is also required.

Strain and Serotype Reference

Mycoplasma Antigen and Tropism Reference

The supplied material describes three antigen directions with high antigen content. Final claims and composition must follow the registered product label.

Antigen DirectionTissue TropismSupplied Antigen ContentProgram Role
CR strainRespiratory tractAt least 1.0 x 10^9 CCUSupports respiratory disease prevention
WH strainReproductive tractAt least 1.0 x 10^9 CCUSupports reproductive tract protection
DM strainJoint cavityAt least 1.0 x 10^9 CCUSupports joint and synovial protection

Product Selection Guide

How to Choose a Mycoplasma Vaccine

Match disease pressure, flock type, production stage and co-infection risk with a registered product in the destination market.

Farm SituationSuggested DirectionKey Check
MG and MS pressureMG + MS inactivated vaccineReview breeder and progeny status
Mycoplasma plus coryza pressureMycoplasma + IC combinationConfirm coryza serotype coverage
Vertical transmission concernBreeder vaccination and monitoringReview hatchery and egg data
Joint disease dominated by MSMS-focused antigen directionConfirm diagnosis and strain suitability

Core Technology

WOLLVAC Mycoplasma Vaccine Technology Highlights

WOLLVAC vaccine directions focus on antigen quality, formulation safety, stable immune response and practical farm use.

01

Endotoxin Control

Processing targets levels at or below 10 EU/mL to reduce endotoxin-related stress.

02

Composite Oil Adjuvant

French-origin composite oil adjuvant supports immune response and stability.

03

Low Viscosity

Viscosity below 30 cP supports easier injection and lower stress.

04

Low-Temperature Emulsification

High-speed shear emulsification protects formulation quality.

05

Uniform Particle Size

The supplied material reports an average particle size of 1.13 micrometers.

06

Closed Pipeline Processing

Closed transfer supports stable particles, low viscosity and consistent absorption.

07

Low Formaldehyde Inactivation

A final formaldehyde concentration of 0.8 per mille is used to reduce side reactions.

Immunization Strategy

Mycoplasma Control Requires Vaccination and Biosecurity

A practical program combines suitable vaccination, clean sourcing, flock management, monitoring and qualified veterinary guidance.

01

Primary Immunization

Primary immunization establishes immune memory with a limited initial antibody response.

02

Booster Immunization

A booster can rapidly increase antibody levels and support longer protection.

03

Control Vertical Transmission

Monitor breeders and hatching eggs because infection can pass to offspring.

04

Improve Hatchery Biosecurity

Use clean sourcing, sanitation and flock separation to limit spread.

05

Monitor Respiratory and Joint Signs

Track respiratory performance, egg quality, joint swelling and growth.

06

Coordinate Veterinary Treatment

Medication decisions should follow diagnosis and veterinary guidance.

Dose, timing and administration must follow the registered label, local regulations and qualified veterinary guidance.

Who This Page Is For

Mycoplasma Vaccine Support for Different Buyers

WOLLVAC supports farms, veterinary teams, distributors and importers with product selection and registration-related information.

FM

Poultry Farms

Assess field signs, flock age, production impact and previous disease history.

VET

Veterinary Teams

Discuss diagnosis, strain or serotype pressure, vaccine timing and combined disease risk.

DI

Distributors

Build a focused product portfolio using existing WOLLVAC vaccine options.

IM

Importers

Request specifications, label information and registration-related documentation.

Need Mycoplasma Vaccine Information for Your Market?

Tell us your country, poultry type, disease concern and current vaccination program. WOLLVAC will help identify suitable product directions.

FAQ

Mycoplasma Vaccine FAQ

Common questions from poultry farms, veterinarians, distributors and importers selecting Mycoplasma vaccines.

What are MG and MS in poultry?

MG means Mycoplasma gallisepticum and MS means Mycoplasma synoviae.

They spread horizontally through respiratory secretions and vertically through eggs.

They affect respiratory and reproductive systems; MS is also associated with joint disease.

Strains may favor respiratory, reproductive or joint tissues and differ in immunogenicity.

Breeder infection can pass through eggs and persist across generations.

The supplied material recommends primary and booster immunization for layer flocks.

Yes. WOLLVAC has combination directions; use must follow the registered label.

Yes. Specifications, labels and registration-related information can be discussed.

Request Mycoplasma Vaccine Product Information

Submit your country, poultry type, disease concern and product requirements. WOLLVAC will help identify suitable vaccine directions.

Support: Product Selection / Label / Specification / Registration Documents

Suitable For: Poultry Farms, Veterinarians, Distributors and Importers

Get Mycoplasma Vaccine Details

    Scroll to Top